We have used high-titer (10(8) ffu/ml) recombinant retroviral vectors
to transfer the P-galactosidase (P-Gal) gene to rat hepatocytes in viv
o. In animals injected twice in the portal blood stream the next day a
fter partial hepatectomy, half of the hepatocytes (46 +/- 17%) express
ed the marker at the end of liver regeneration. The number of positive
cells closely correlated with the viral titer as well as with P-Gal e
nzymatic activity present in the whole liver, Because genes transferre
d via retroviral vectors in the liver are known to be expressed perman
ently, our present results open new possibilities for the development
of gene therapy protocols for hereditary liver diseases using recombin
ant retroviral vectors.